Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pinellia ternata, also known as Ban-xia, is a traditional Chinese medicinal herb with a history of approximately 2000 years, primarily used for alleviating cough and vomiting. Its therapeutic applications extend to treating cancer (raw tubers) and addressing coughing and phlegm (processed tubers). Research indicates its efficacy in various conditions, including suppressing *Helicobacter pylori* colonization, alleviating chronic obstructive pulmonary disease (COPD) through components like baicalein, and managing obesity-type polycystic ovary syndrome (PCOS) as part of traditional prescriptions. It also shows potential in treating chemotherapy-induced nausea and vomiting, neuroinflammation related to Alzheimer's disease, and papillary thyroid carcinoma. The herb's diverse pharmacological activities are attributed to its components, such as polysaccharides, which exhibit immunostimulatory effects by upregulating NF-κB and MAPK pathways, and baicalein, which inhibits HIF1A-mediated oxidative stress and inflammation. Additionally, Pinellia ternata contains compounds that regulate heat tolerance in plants and confer resistance against insect pests. Its polysaccharides, like PTTBP-2-2, demonstrate anti-neuroinflammatory activity by regulating NF-κB and Nrf2/HO-1 signaling pathways. The herb is also being explored for synthesizing bioactive selenium nanoparticles with antioxidant and antibacterial properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Pinellia ternata.